BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37462809)

  • 1. The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.
    Vuong HG; Dunn IF
    Endocrine; 2023 Dec; 82(3):527-535. PubMed ID: 37462809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of mutations in protein deubiquitinases genes and
    Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
    Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
    Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma knife radiosurgery in patients with Cushing's disease: Comparison of aggressive pituitary corticotroph tumor versus corticotroph adenoma.
    Kara M; Güdük M; Samanci Y; Yilmaz M; Şengöz M; Peker S
    Clin Neurol Neurosurg; 2020 Oct; 197():106151. PubMed ID: 32882541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
    Rak B; Maksymowicz M; Pękul M; Zieliński G
    Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerning the article "Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia".
    Saeger W
    Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):68. PubMed ID: 20127571
    [No Abstract]   [Full Text] [Related]  

  • 8. Silent corticotroph adenomas.
    Ben-Shlomo A; Cooper O
    Pituitary; 2018 Apr; 21(2):183-193. PubMed ID: 29344907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
    Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study.
    Cohen-Inbar O; Xu Z; Lee CC; Wu CC; Chytka T; Silva D; Sharma M; Radwan H; Grills IS; Nguyen B; Siddiqui Z; Mathieu D; Iorio-Morin C; Wolf A; Cifarelli CP; Cifarelli DT; Lunsford LD; Kondziolka D; Sheehan JP
    J Neurooncol; 2017 Oct; 135(1):67-74. PubMed ID: 28913674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTH adenomas transforming their clinical expression: report of 5 cases.
    Zoli M; Faustini-Fustini M; Mazzatenta D; Marucci G; De Carlo E; Bacci A; Pasquini E; Lanzino G; Frank G
    Neurosurg Focus; 2015 Feb; 38(2):E15. PubMed ID: 25639317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
    Bradley KJ; Wass JA; Turner HE
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Survival After Transformation of an Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma.
    Rotman LE; Vaughan TB; Hackney JR; Riley KO
    World Neurosurg; 2019 Feb; 122():417-423. PubMed ID: 30447452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.
    Uzilov AV; Taik P; Cheesman KC; Javanmard P; Ying K; Roehnelt A; Wang H; Fink MY; Lau CY; Moe AS; Villar J; Bederson JB; Stewart AF; Donovan MJ; Mahajan M; Sebra R; Post KD; Chen R; Geer EB
    J Clin Endocrinol Metab; 2021 Mar; 106(3):826-842. PubMed ID: 33221858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel
    Uzilov AV; Cheesman KC; Fink MY; Newman LC; Pandya C; Lalazar Y; Hefti M; Fowkes M; Deikus G; Lau CY; Moe AS; Kinoshita Y; Kasai Y; Zweig M; Gupta A; Starcevic D; Mahajan M; Schadt EE; Post KD; Donovan MJ; Sebra R; Chen R; Geer EB
    Cold Spring Harb Mol Case Stud; 2017 May; 3(3):a001602. PubMed ID: 28487882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
    Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
    Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
    Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.